Search all trials

Find therapies in clinical trials near you – page 75

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Peripheral T-cell lymphoma unspecified

Not recruiting

Registered drugNo placebo

Study on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

Anal fistula

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn's Disease and Complex Perianal Fistulas

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Fallopian tube cancer+1

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Vitiligo

Not recruiting

Investigational

Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Mk-6194

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Boserolimab

Contact Research Centre

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Not recruiting

Registered drugNo placebo

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Aminocaproic Acid

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Mk-0482

Contact Research Centre

Follicular lymphoma+1

Not recruiting

Registered drug

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Boserolimab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study on Patient Preference for Nivolumab and Relatlimab Administration Methods in Melanoma Patients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Registered drugNo placebo

Spain

Participants:65+ years
Substances:Anakinra

Contact Research Centre

Find therapies in clinical trials near you – page 75

978 trials match your criteria

Peripheral T-cell lymphoma unspecified

Study on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression

Anal fistula

Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn's Disease and Complex Perianal Fistulas

Gastroenteropancreatic neuroendocrine tumour disease

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Fallopian tube cancer+1

Study of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer

Vitiligo

Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo

Non-small cell lung cancer

Study of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Non-small cell lung cancer

Study to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment

Follicular lymphoma+1

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Non-small cell lung cancer

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Malignant melanoma

Study on Patient Preference for Nivolumab and Relatlimab Administration Methods in Melanoma Patients

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.